ANI Pharma Reveals Clearance From FTC For Acquisition Of Novitium

ANI Pharmaceuticals, Inc. (ANIP) Thursday said the U.S. Federal Trade
Commission has accepted the proposed consent order to acquire Novitium Pharma. As per the agreement, FTC's acceptance satisfies all required antitrust clearances.

ANI, a diversified biopharmaceutical company, further noted that the acquisition will be completed on or about November 18, 2021.

Earlier in March, ANI Pharma had announced its plan to acquire New Jersey-based privately held Novitium for $163.million. The deal includes $89.5 million in cash and $74 million in equity plus two potential future cash earn-outs of up to $46.5 million.

The transaction is expected to be immediately accretive to ANI's adjusted EBITDA and long-term growth.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. air travel industry is going through its worst crisis since the troubled travel time during the peek pandemic struggles, with thousands of flights across the country being cancelled or getting delayed. The aviation crisis, as millions are preparing to travel during the upcoming July 4th holiday weekend, is mainly attributed to the staffing issues at airlines, ... The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert for Siluriformes products imported by Carlstadt, New Jersey- based Grand BK Corp. The products were imported from Korea, a country ineligible to export Siluriformes products to the United States. Blount Fine Foods is recalling a limited amount of Panera at Home Southwest Corn Chowder citing undeclared wheat allergen, the U.S. Food and Drug Administration said. The recall involves a single lot of 16 oz. product with UPC Code 077958690812, lot number 042122-2K and "Use By" date of 6/30/22 that comes around 2,569 cases in total. The recall is limited to 1 SKU of 16 oz.
Follow RTT